New CPT Codes Debut for Digital Pathology Services

By Scott Wallask | From the Volume XXX No. 2 – January 23, 2023 Issue

CEO SUMMARY: New digital pathology CPT codes took effect Jan. 1. Because the new codes are designated as Category III, they are not subject to Medicare and private payer reimbursement yet. Instead, federal health officials will monitor the use of the new codes in 2023 to determine h…

Read More

---

June 6, 2022 Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXIX, No. 8 – June 6, 2022 Issue

Monkeypox is the latest disease showing up in the United States. That means hospital laboratories will want to be ready to diagnose monkeypox cases that show up in their emergency departments. An official from the Centers for Disease Control and Prevention (CDC) says it is exploring the possib…

Read More

---

Innovation Showcased at Executive War College

By Robert Michel | From the Volume XXIX, No. 7 – May 16, 2022 Issue

CEO SUMMARY: This year’s Executive War College on Laboratory and Pathology Management proved to be a high-energy event. A record 900 attendees showed up and responded enthusiastically to visions and predictions of a post-COVID-19 healthcare system that hungers for large volumes of…

Read More

---

April 4, 2022, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXIX, No. 5 – April 4, 2022 Issue

On March 22, the U.S. Health Resources and Services Administration (HRSA) announced that its COVID-19 Uninsured Program had stopped accepting claims for related laboratory testing due to lack of sufficient funds. This development potentially affects 8.6% of the nation’s population which does…

Read More

---

March 14, 2022 Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXIX, No. 4 – March 14, 2022 Issue

Telehealth proved to be popular with Medicare patients during the SARS-CoV-2 pandemic. The federal U.S. Department of Health and Human Services (HHS) reported telehealth visits for Medicare beneficiaries increased in 2020 by an incredible 63 times—from approximately 840,000 in 2019 to 52.7 m…

Read More

---

Newsmaker Interview

By Robert Michel | From the Volume XXIX, No. 2 – January 31, 2022 Issue

  …

Read More

---

XIFIN’s Acquisition of OmniSYS Will Unite Lab with Pharmacy

By Robert Michel

This is an excerpt of a 1,829-word article in the January 10, 2022 issue of  THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: XIFIN’s acquisition of OmniSys, a pharmacy technology company, is the latest evidence that …

Read More

---

2021 Closes with Two Major Lab Industry Events

By R. Lewis Dark | From the Volume XXIX, No. 1 – January 10, 2022 Issue

Normally, the time around Christmas and New Year passes quietly, typically without any significant developments. Such was not the case for the clinical laboratory industry in the last month of 2021 because of two announcements, each of which confirms ongoing market trends in healthcare and the lab te…

Read More

---

XIFIN Buys OmniSYS, Bridges Lab to Pharmacy

By Robert Michel | From the Volume XXIX, No. 1 – January 10, 2022 Issue

CEO SUMMARY: XIFIN’s acquisition of pharmacy technology company OmniSYS is the latest evidence that retail pharmacies are preparing to become a new front door to healthcare for consumers. The deal allows XIFIN to bring clinical lab information about patients directly to pharmacist…

Read More

---

Labs, Pathology Groups Face Reduced Revenue

By Robert Michel | From the Volume XXVIII, No. 17 – December 20, 2021 Issue

CEO SUMMARY: In recent years, certain clinical laboratories and pathology groups found they can generate more revenue by remaining out of network whenever possible. But when the No Surprises Act goes into effect Jan. 1, labs and pathologists may find advantages in being in network. …

Read More

---